Mohamed Hamdani Email

VP, Biometrics and DM . Larimar Therapeutics

Current Roles

Employees:
55
Revenue:
$8.5M
About
Larimar Therapeutics, Inc. (Nasdaq:LRMR), is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases. The company’s lead compound, CTI-1601, is currently being evaluated in a Phase 1 clinical program as a potential treatment for Friedreich’s ataxia, a rare and progressive genetic disease. Larimar also plans to use its intracellular delivery platform to design other fusion proteins to target additional rare diseases characterized by deficiencies in intracellular bioactive compounds. For more information, please visit: https://larimartx.com.
Larimar Therapeutics Address
Three Bala Plaza East
Bala Cynwyd, PA
United States
Larimar Therapeutics Email

Past Companies

Larimar Therapeutics Inc.Vice President, Biometrics and DM
Apellis PharmaceuticalsVice President, Biometrics and DM
Apellis PharmaceuticalsSenior Director- Head of Biometrics

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.